Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The AAPS Journal|August 23, 2012
Metrics for the evaluation of bioequivalence of modified-release formulationsLaszlo Endrenyi, Laszlo Tothfalusi
British Journal of Clinical Pharmacology|August 23, 2007
Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tabletsLaszlo Tothfalusi, Szilvia Speidl, Laszlo Endrenyi
Clinical Pharmacokinetics|October 13, 2009
Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalenceLaszlo Tothfalusi, Laszlo Endrenyi, Alfredo Garcia Arieta
The AAPS Journal|February 4, 2017
The Two Main Goals of Bioequivalence StudiesLaszlo Endrenyi, Henning H Blume, Laszlo Tothfalusi
Clinical Therapeutics|August 19, 2011
The need for additional metrics to assess therapeutic equivalence of some multiphasic modified-release productsPeter M Kondra, Laszlo Endrenyi, Laszlo Tothfalusi
Statistics in Medicine|August 23, 2012
On the interchangeability of biologic drug productsLaszlo Endrenyi, Chiann Chang, Shein-Chung Chow, et al.
Scientific Reports|February 7, 2025
Corticosteroid-sparing topical treatment with cyclosporin for juvenile keratoconjunctivitisAmarilla Barcsay-Veres, Anita Csorba, Illes Kovacs, et al.
Neuropeptides|February 20, 2016
Chronic venlafaxine treatment fails to alter the levels of galanin system transcripts in normal ratsPeter Petschner, Gabriella Juhasz, Viola Tamasi, et al.
Pageof 3